Effects of β-adrenoceptor antagonist administration on β₂-adrenoceptor density in human lymphocytes: the role of the intrinsic sympathomimetic activityBRODDE, O.-E; DAUL, A; STUKA, N et al.Naunyn-Schmiedeberg's archives of pharmacology. 1985, Vol 328, Num 4, pp 417-422, issn 0028-1298Article

EFFECT OF MEPINDOLOL ON SERUM LIPIDSMARTIGNONI A; PERANI G; FINARDI G et al.1982; INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY, THERAPY AND TOXICOLOGY (1980); ISSN 506508; DEU; DA. 1982; VOL. 20; NO 11; PP. 543-545; BIBL. 20 REF.Article

HAEMODYNAMISCHE VERAENDERUNGEN UNTER KOERPERLICHER BELASTUNG BEI PATIENTEN MIT KORONARER HERZKRANKHEIT VOR UND NACH MEPINDOLOL-SULFAT. = MODIFICATIONS HEMODYNAMIQUES SOUS EFFORT CHEZ DES MALADES AVEC CARDIOPATHIE CORONAIRE AVANT ET APRES SULFATE DE MEPINDOLOLBONELLI J; MAGOMETSCHNIGG D; HITZENBERGER G et al.1978; Z. KARDIOL.; DTSCH.; DA. 1978; VOL. 67; NO 1; PP. 51-56; ABS. ANGL.; BIBL. 17 REF.Article

DER EINFLUSS VON NITROGLYZERIN AUF DIE BELASTUNGSHAEMODYNAMIK KORONARKRANKER BEI VORBEHANDLUNG MIT BETA-REZEPTORENBLOCKERN (MEPINDOLOL, OXPRENOLOL) UND EINEM KALZIUMANTAGONISTEN (FENDILIN) = EFFETS DE LA NITROGLYCERINE SUR L'HEMODYNAMIQUE APRES EXERCICE CHEZ DES SUJETS AVEC CARDIOPATHIE CORONAIRE SOUS TRAITEMENT PAR BETA -BLOQUANTS (MEPINDOLOL, OXPRENOLOL) ET PAR UN ANTAGONISTE DU CALCIUM (FENDILINE)REITERER W.1980; WIEN. MED. WOCHENSCHR.; ISSN 0043-5341; AUT; DA. 1980; VOL. 130; NO 23; PP. 772-777; ABS. ENG; BIBL. 33 REF.Article

HEMODYNAMIC CHARACTERIZATION OF A NEW BETA-RECEPTOR BLOCKER: MEPINDOLOL AT REST, DURING ERGOMETER EXERCISE AND IN THE ISOPROTERENOL STUDY IN COMPARISON WITH PRACTOLOL AND PINDOLOL.BONELLI J.1977; INTERNATION. J. CLIN. PHARMACOL. BIOPHARM.; GERM.; DA. 1977; VOL. 15; NO 7; PP. 325-331; BIBL. 17 REF.Article

DETERMINATION OF PLASMA MEPINDOLOL LEVELS BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY AND ELECTROCHEMICAL DETECTIONKRAUSE W.1980; J. CHROMATOGR.; NLD; DA. 1980; VOL. 181; NO 1; PP. 67-75; BIBL. 12 REF.Article

EVALUATING MEPINDOLOL IN A TEST MODEL OF EXAMINATION ANXIETY IN STUDENTSKROPE P; KOHRS A; OTT H et al.1982; PHARMACOPSYCHIATRIA; ISSN 0720-4280; DEU; DA. 1982; VOL. 15; NO 2; PP. 41-47; ABS. GER; BIBL. 2 P.Article

PHARMACOKINETICS AND PHARMACODYNAMICS OF MEPINDOLOL SULPHATEBONELLI J; HITZENBERGER G; KRAUSE W et al.1980; INT. J. CLIN. PHARMACOL. THER. TOXICOL.; DEU; DA. 1980; VOL. 18; NO 4; PP. 169-176; BIBL. 7 REF.Article

ANTIANGINAL EFFECT OF A NEW BETA-ADRENERGIC BLOCKER, MEPINDOLOL (CARIDIAN) IN PATIENTS WITH ISCHEMIC HEART DISEASESUKERMAN M; VELASCO M; BIRNBAUM B et al.1979; CURR. THERAPEUT. RES.; USA; DA. 1979; VOL. 25; NO 3; PP. 384-388; BIBL. 5 REF.Article

Acute and chronic effects of the beta-receptor blocker mepindolol on hemodynamics and the portal circulationWINK, K.International journal of clinical pharmacology, therapy and toxicology (1980). 1984, Vol 22, Num 8, pp 447-450, issn 0174-4879Article

The influence of propanolol, metoprolol, and mepindolol on mucociliary clearance in coronary heart disease patients without pulmonary diseaseDOROW, P; WEISS, T; FELIX, R et al.International journal of clinical pharmacology, therapy and toxicology (1980). 1984, Vol 22, Num 2, pp 108-111, issn 0174-4879Article

Pharmacokinetics of mepindolol in patients with chronic renal failureKRAUSE, W; KAMPF, D; FISCHER, H.-C et al.European journal of clinical pharmacology. 1984, Vol 27, Num 4, pp 429-433, issn 0031-6970Article

EFFECTS OF DIFFERENT BETA-RECEPTOR ANTAGONISTS ON HANDGRIP IN ESSENTIAL HYPERTENSIONFOGARI R; MARCHESI E; BELLOMO G et al.1982; INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY, THERAPY AND TOXICOLOGY (1980); ISSN 506508; DEU; DA. 1982; VOL. 20; NO 11; PP. 551-553; BIBL. 11 REF.Article

MULTICENTER EVALUATION OF MEPINDOLOL AND OF MEPINDOLOL PLUS HYDROCHLOROTHIAZIDE IN ESSENTIAL HYPERTENSIONMASONI A; GALASSI A; GINEVRINO P et al.1982; INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY, THERAPY AND TOXICOLOGY (1980); ISSN 506508; DEU; DA. 1982; VOL. 20; NO 11; PP. 546-550; BIBL. 5 REF.Article

ANTIANGINAL AND ANTIHYPERTENSIVE PROPERTIES OF A NEW NON-SELECTIVE BETA-ADRENERGIC BLOCKER-MEPINDOLOL (SHE 222)SUKERMAN M; VELASCO M; BIRNBAUM B et al.1980; CURR. THERAPEUT. RES.; USA; DA. 1980; VOL. 27; NO 2; PP. 178-189; BIBL. 12 REF.Article

TRANSFER OF MEPINDOLOL TO NEWBORNS BY BREAST-FEEDING MOTHERS AFTER SINGLE AND REPEATED DAILY DOSESKRAUSE W; STOPPELLI I; MILIA S et al.1982; EUR. J. CLIN. PHARMACOL.; ISSN 0031-6970; DEU; DA. 1982; VOL. 22; NO 1; PP. 53-55; BIBL. 18 REF.Article

COMPARATIVE HAEMODYNAMIC STUDIES WITH MEPINDOLOL-SULPHATE (SH E 222) AND PROPANOLOL (INDERAL^REG., DOCITON^REG.) IN THE ISOPROTERENOL TESTBONELLI J.1978; J. INTERNATION. MED. RES.; GBR; DA. 1978; VOL. 6; NO 4; PP. 317-325; BIBL. 8 REF.Article

COMPARATIVE INVESTIGATION OF THE RESPIRATORY AND CARDIOVASCULAR EFFECT OF MEPINDOLOL, PROPANOLOL AND PINDOLOL IN ASTHMATIC PATIENTS.BEUMER HM; TEIRLINCK C; WISEMAN RA et al.1978; INTERNATION. J. CLIN. PHARMACOL. BIOPHARM.; GERM.; DA. 1978; VOL. 16; NO 6; PP. 249-253; BIBL. 11 REF.Article

Pharmacological studies on the intrinsic sympathomimetic activity of the β-adrenoceptor antagonist mepindololBECKMANN, R; MÜLLER, B; SCHRÖDER, G et al.Arzneimittel-Forschung. 1986, Vol 36, Num 5, pp 811-813, issn 0004-4172Article

Mepindolol reduces myocardial necrosis in rats with coronary artery occlusionCHIARIELLO, M; AMBROSIO, G; CAPPELLI-BIGAZZI, M et al.Journal of cardiovascular pharmacology. 1985, Vol 7, Num 3, pp 525-531, issn 0160-2446Article

The duration of action of mepindolol in stable anginaREGOLI, F; CARNESECCHI, C; GIUSTI, C et al.Current therapeutic research. 1985, Vol 38, Num 5, pp 728-732, issn 0011-393XArticle

Ventilatory response to carbon dioxide and to isometric muscle contraction after administration of placebo, propranolol, mepindolol and salbutamolBOSISIO, E; COLOMBO, F; SEGA, R et al.Respiration (Basel). 1985, Vol 48, Num 2, pp 116-121, issn 0025-7931Article

Effect of mepindolol on blood pressure variability in hypertensive patientsLAURO, R; DEL MASTRO, S; OTTOLENGHI, L et al.Current therapeutic research. 1984, Vol 36, Num 2, pp 374-378, issn 0011-393XArticle

Evaluation of the therapeutic effect of transdermal β-blocker therapy in patients with essential hypertensionSPIEKER, C; VETTER, W; ZIDEK, W et al.Arzneimittel-Forschung. 1989, Vol 39, Num 11a, pp 1512-1514, issn 0004-4172Article

Isometric exercise before and after beta-receptor blockade with propranolol and mepindolol sulfateBONELLI, J.International journal of clinical pharmacology, therapy and toxicology (1980). 1984, Vol 22, Num 4, pp 189-193, issn 0174-4879Article